More than 90% of triple-negative breast cancers (TNBC) and 80% of pancreatic ductal adenocarcinoma (PDAC), both highly aggressive cancer types, present with the aberrantly expressed MUC1 [37,38]. Here, MUC1 is linked to cancer.